DCC
DCC (DCC netrin 1 receptor, also known as IGDCC1 and NTN1R1) is a transmembrane receptor for netrin that guides axons in the developing nervous system. Originally named deleted in colorectal carcinoma, it also acts as a dependence receptor and tumour suppressor. Browse Assay Genie's current range of DCC research reagents below, or read on for the biology behind the target.
DCC is a receptor for netrin and is required for axon guidance. When bound by ligand, it mediates attraction of neuronal growth cones in the developing nervous system, steering them towards sources of netrin 1. Its association with UNC5 proteins may instead trigger signalling for axon repulsion. The cytoplasmic tail interacts with the tyrosine kinases Src and focal adhesion kinase (FAK, also known as PTK2) to mediate axon attraction.
DCC also functions as a dependence receptor: when it is not associated with netrin ligand, it is required for the induction of apoptosis. The protein partially localises to lipid rafts. It is a transmembrane protein belonging to the immunoglobulin superfamily of cell adhesion molecules and to the DCC family. The HGNC gene groups for the DCC gene include fibronectin type III domain containing, I-set domain containing, and microRNA protein coding host genes.
The gene was first named deleted in colorectal carcinoma, reflecting its role as a tumour suppressor. DCC is frequently mutated or downregulated in colorectal cancer and esophageal carcinoma. Researchers studying DCC therefore work across neurodevelopment, cell death signalling and cancer biology, and reagents such as a DCC antibody or DCC ELISA kit are commonly used to examine expression of the protein. Mouse and rat orthologues (both Dcc) are available for comparative work.
DCC mediates netrin-dependent attraction of neuronal growth cones, making it central to studies of how axons navigate in the developing nervous system.
As a dependence receptor, DCC induces apoptosis when not bound to netrin ligand, offering a model for ligand-dependent survival signalling.
DCC acts as a tumour suppressor and is frequently mutated or downregulated in colorectal cancer and esophageal carcinoma.
The cytoplasmic tail interacts with Src and FAK, and DCC associates with UNC5 proteins, allowing analysis of attraction versus repulsion signalling.
DCC is a receptor for netrin that is required for axon guidance. Upon ligand binding it mediates attraction of neuronal growth cones in the developing nervous system. Without netrin it acts as a dependence receptor and is required for apoptosis induction. It is also implicated as a tumour suppressor.
The HGNC name is DCC netrin 1 receptor, and UniProt lists it as netrin receptor DCC. Aliases and previous symbols include IGDCC1 and NTN1R1. The original name, deleted in colorectal carcinoma, explains the gene symbol and its link to cancer.
DCC is a tumour suppressor that is frequently mutated or downregulated in colorectal cancer and esophageal carcinoma. Orthologues exist in mouse and rat, both named Dcc. Check the datasheet of any product for its validated reactivity.
Netrin ligands, UNC5 co-receptors, Src-family and focal adhesion kinases and other axon guidance and tumour suppressor targets with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P43146; product specifications from Assay Genie datasheets.